The HeDS-D2R Platform is seeking two interdisciplinary interns passionate about the intersection of biology, data science, and RNA therapeutics to join the team and contribute to a project that makes a real difference in the genomics and research community.
Two Project Tracks:
Part of the largest CIHR-led cancer prevention investment, McGill researchers will develop approaches to reduce cancer risk and improve early detection
Montreal, QC, February 25, 2026 - McGill’s DNA to RNA (D2R) Initiative - a $165M initiative funded by the Government of Canada through the Canada First Research Excellence Fund to turn genomic discoveries into RNA-based treatments - is expanding its global health impact.
McGill Researchers - as part of an initiative led by the McGill Web Services team, it is now possible to request a centrally supported website to showcase your research or lab in the new WMS system, complete with a new specially designed, ready-to-customize website template.
Main features included:
Attractive, image-based layouts pre-filled with placeholder content for easy updates.
“Innovation” is everywhere these days—but beyond the buzzword, what does it really mean for a young company, and how can you turn it into a concrete competitive advantage? This presentation demystifies intellectual property (IP) and shows why it matters far more than many founders think.
We’ll explore briefly the different forms of IP and clarify what each protects in practical terms. You’ll discover when an idea becomes an “invention,” when you should consider filing a patent, and who the right professionals are to guide you along the way.
A half day showcase of D2R and the National Research Council’s shared biomanufacturing and bioengineering research priorities. Researchers from both the NRC and the D2R community will present on their platform and biomanufacturing-aligned work, including gene editing, mRNA production and optimization, lipid nanoparticle formulation, and RNA therapeutic delivery systems.
Montreal, QC, February 5, 2026 — McGill University researchers, supported by the DNA to RNA (D2R) initiative and Moderna, are launching a pioneering research project that aims to further the fundamentals of ribonucleic acid (RNA) medicines by enhancing our understanding of the three-dimensional structure of full-length messenger RNA (mRNA).
56 McGill research projects were awarded funding through CIHR’s Fall 2025 Project Grant competition, to support high-potential health research across all areas and career stages.
The 8th edition of the International Conference on Governance and Innovation: Cybersecurity and Artificial Intelligence will take place June 17–19, 2026, at the Université du Québec en Outaouais (UQO) in Gatineau, Quebec, Canada.
This international conference explores the accelerating convergence of governance, innovation, cybersecurity, and artificial intelligence (AI) in a rapidly changing digital world. Thematic areas of the conference include:
Montreal, January 21, 2026 – The D2R | DNA to RNA Initiative at McGill University proudly announces the recipients of the inaugural Postdoctoral Scholar Awards. Alongside the Master’s and Doctoral Scholar awards, this funding program recognizes outstanding trainees working on diverse D2R-aligned research projects and brings outstanding postdoctoral researchers from across Canada and abroad to the D2R Initiative.
A McGill research team is tackling one of AI’s fastest-moving challenges: how software developers can steer and safeguard code as AI systems become capable of writing large portions of software on their own.
Ebenezer Miezah Kwofie, Assistant Professor in the Bioresource Engineering Department, has been awarded one of eight science diplomacy chairs newly created by the Fonds de recherche du Québec (FRQ).
D2R's funded-researcher Thomas Duchaine recently sat down with Radio-Canada to discuss emerging research suggesting that RNA vaccines developed for COVID-19 may also enhance the effectiveness of certain cancer treatments.
